Fig. 3.From: The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer78-year-old man presents with PSA 15.90Â ng/mL and PSA density 0.14Â ng/mL2 for PET-targeted HIFU of a PI-RADSÂ 5 lesion in the right posterior apex. Pre-therapy 68Â Ga-PSMA11 AÂ and 68Â Ga-RM2 CÂ axial PET, axial fused PET/MRI, MRI, and MIP images show concordant focal uptake in the right posterior prostate (red arrows). After HIFU, 68Â Ga-PSMA11 BÂ and 68Â Ga-RM2 DÂ axial PET, axial fused PET/MRI, MRI, and MIP show structural changes with urine pooling in the treated area (blue arrows) but no pathologic uptake. Biopsy confirmed no evidence of PC in the treated areaBack to article page